ArticleJACC. Advances2026
Prevalence of Cardiovascular Disease and Risk Factors Among Cancer Patients: 5-Year National Inpatient Sample Analysis.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular disease (CVD) and cancer are the leading causes of mortality in the United States. Although CVD influences cancer management and outcomes, data on CVD among U.S. cancer patients are limited.
objectivesThe objective of the study was to describe the prevalence and distribution of CVD among hospitalized U.S. cancer patients.
methodsWe analyzed prevalence of CVD by age, sex, race, and cancer type among hospitalized cancer patients from 2016 to 2020 using the National Inpatient Sample database. Weighted estimates were generated per National Inpatient Sample guidelines. Categorical data are reported as counts, percentages, and 95% CIs, and continuous data as mean ± SE.
resultsAn estimated 24,748,225 hospital encounters (mean age 68.0 ± 16.1 years) were analyzed. Coronary artery disease (CAD) was the most prevalent CVD (23.9%), followed by atrial fibrillation (20.3%), and heart failure (18.3%). Men had higher prevalence of heart failure, atrial fibrillation, CAD, myocardial infarction, revascularization, cardiac arrest, and stroke compared with women. Black patients had higher prevalence of hypertension (75.2%), obesity (15.5%), end-stage kidney disease (6.9%), and pulmonary hypertension (5.1%). Mortality was highest among Asian/Pacific Islanders, Native Americans, and Blacks (5.5%, 4.9% and 4.7%, respectively), compared with Whites (3.9%). Among cancer types, patients with prostate cancer had the highest prevalence of CVD.
conclusionsCAD is the most common CVD among hospitalized patients with cancer. Men, Black patients, and those with prostate cancer face disproportionately higher burden of CVD; and in-hospital mortality was highest among non-Whites, underscoring the need for proactive, targeted cardiovascular care in oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.